Stay updated with breaking news from General Brigham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study has shed light on the accuracy of ChatGPT in clinical decision making. A recent study led by researchers from Mass General Brigham has shed light on the accuracy of ChatGPT in clinical decision making.
The AI chatbot was found to be 72 percent accurate in clinical decision-making in health care settings, and could even prescribe medication.
Mass General Brigham investigators found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses to making final diagnoses and care management decisions.
The study presented ChatGPT with 36 clinical scenarios and found it can be roughly as accurate as a developing practitioner in the early stages of their career.
A team led by researchers from Mass Eye and Ear, a member of Mass General Brigham, reports the results of a phase I trial of a revolutionary stem cell treatment called cultivated autologous limbal epithelial cell transplantation (CALEC), which was found to be safe and well-tolerated over the short term in four patients with significant chemical burns in one eye.